Patents by Inventor H. Hugh Fudenberg

H. Hugh Fudenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4801533
    Abstract: Alzheimer's Disease (AD) sufferers may be diagnosed by examination of T-cells from their peripheral blood. AD is marked by increased appearance of alpha-1 acid glycoprotein (AGP) on the surface of such cells. Among AD subjects normal for AGP, a subpopoulation exists which show elevated AMLR response as compared to age-matched controls. These tests may be used to diagnose AD or to screen possible therapeutic agents.
    Type: Grant
    Filed: June 25, 1986
    Date of Patent: January 31, 1989
    Inventor: H. Hugh Fudenberg
  • Patent number: 4322274
    Abstract: An immunologic method has been devised enabling diagnosis of patients with cystic fibrosis, as well as asymptomatic carriers of the cystic fibrosis gene. Mono-specific antibody to Cystic Fibrosis Protein (CFP) is inserted into a first position on an electrophoresis plate. A body fluid from the subject to be tested is placed into a second position on the plate. An electrical potential is imposed across the positions with the anode being adjacent to the section containing the serum and the cathode being adjacent to the section containing the antibody. The presence of Cystic Fibrosis Protein is indicated by one or more precipitation zones forming where the body fluid proteins meet the antibody due to movement induced by an applied electrical potential. The relative position of the precipitation zone between the first and second positions, or the area of the precipitation zone, indicates a concentration of the Cystic Fibrosis Protein.
    Type: Grant
    Filed: August 28, 1980
    Date of Patent: March 30, 1982
    Inventors: Gregory B. Wilson, H. Hugh Fudenberg
  • Patent number: 3991182
    Abstract: A method of treating human patients suffering from immune deficiency diseases by extracting a "transfer factor" from leucocytes obtained from healthy donors who exhibit immune response to said diseases and injecting said "transfer factor" into said diseased patients to thereby suppress disease symptoms.
    Type: Grant
    Filed: November 8, 1973
    Date of Patent: November 9, 1976
    Assignee: The Regents of the University of California
    Inventors: Lynn E. Spitler, Alan S. Levin, H. Hugh Fudenberg, Daniel P. Stites